Vondra V
Plicní oddelení NZZ, Kartouzská 6, Praha 5.
Vnitr Lek. 2004 Sep;50(9):654-8.
COPD mortality is a world-wide growing problem. COPD is the fifth leading cause of mortality among all diseases now and is projected to be the third one in 2020. In the USA died 119,000 inhabitants in 2001. The Czech republic mortality for COPD in the same year was: men 21.3/100,000 inhabitants, women 11.6/100,000; this represents total number of 1666 deaths for COPD. Prevalence of COPD is from 4.5% to 11% in developed countries of Europe and in the USA; prevalence in the Czech republic is 7.7%. Total economic cost of COPD reaches in the USA nearly the same value as cost of lung cancer. The cost is increasing with severity of the disease and with hospitalization, intensive care unit treatment especially. The average length of hospitalization for COPD is in the USA 6.9 days, in Italy 10.6 days, in the Czech republic 15.8 days. Increasing lost of life years by premature death and inability to work (Disability-Adjusted Life Year--DALY system) in developed countries moves COPD from current 12th positron to the 5th one. Quality of life of COPD patients is decreased mainly in domain of physical activity in subjects with respiratory insufficiency on home long term oxygen therapy.
慢性阻塞性肺疾病（COPD）导致的死亡率是一个在全球范围内日益严重的问题。COPD是目前所有疾病中导致死亡的第五大主要原因，预计到2020年将升至第三位。2001年，美国有119,000人死于COPD。同年，捷克共和国COPD的死亡率为：男性每10万居民中有21.3人死亡，女性为每10万居民中有11.6人死亡；这意味着因COPD死亡的总人数为1666人。在欧洲发达国家和美国，COPD的患病率为4.5%至11%；捷克共和国的患病率为7.7%。在美国，COPD的总经济成本几乎与肺癌的成本相当。随着疾病严重程度的增加以及住院治疗，尤其是重症监护病房治疗，成本也在上升。在美国，COPD患者的平均住院时间为6.9天，在意大利为10.6天，在捷克共和国为15.8天。在发达国家，由于过早死亡和无法工作导致的生命年损失增加（伤残调整生命年——DALY系统），使得COPD从目前的第12位升至第5位。对于长期在家接受氧气治疗且存在呼吸功能不全的COPD患者，其生活质量主要在身体活动方面有所下降。
